Merck is a premier research-intensive biopharmaceutical company at the forefront of delivering innovative health solutions for the prevention and treatment of diseases in people and animals. With a history of over 130 years, the company has developed important medicines and vaccines, aiming to save and improve lives globally. Merck fosters a diverse and inclusive global workforce and operates responsibly to enable a safe, sustainable, and healthy future for all people and communities.

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

COM:MERCKGROUP

Merck

Last Close

153.60

05/11 09:04

Market Cap

65.02B

Beta: -

Volume Today

9.56K

Avg: -

market

industry

website

crunchbase

ipo date

peer of

competitor of

Metrics